Edwards Lifesciences Corp. Is Pulling Back After Q4 Report

Edwards Lifesciences Corp. (EW) reported fourth quarter EPS of $0.84 after the bell Thursday, which fell short of the consensus estimate of $0.85. The company expects to report first quarter EPS of $0.77 to $0.81 and full year 2010 EPS of $3.50 to $3.60. The consensus estimates are for EPS of $0.82 and $3.56. The stock is now down 2.36 on 29K shares.

Edwards Lifesciences fell in the first hour of trade Thursday and declined for the majority of the afternoon. Shares finished down by 2.78 at $89.66 on above average volume.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com